Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.

Koopmann J, Fedarko NS, Jain A, Maitra A, Iacobuzio-Donahue C, Rahman A, Hruban RH, Yeo CJ, Goggins M. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):487-91.

View in: PubMed